
5-trans-Bimatoprost
CAS:
Ref. 3D-FB18598
5mg
486.00€
10mg
729.00€
25mg
920.00€
50mg
1,085.00€
100mg
1,518.00€

Product Information
Name:5-trans-Bimatoprost
Synonyms:
- (5E)-7-[(1R,2R,3R,5S)-3,5-Dihydroxy-2-[(1E,3S)-3-hydroxy-5-phenyl-1-penten-1-yl]cyclopentyl]-N-ethyl-5-heptenamide
Brand:Biosynth
Description:5-trans-Bimatoprost is a synthetic prostaglandin analog that inhibits the activity of cyclooxygenase, leading to the production of vasodilatory and anti-inflammatory prostanoids. It is used in ophthalmology as a glaucoma treatment. 5-trans-Bimatoprost is also used for the treatment of glaucoma, which can be caused by increased intraocular pressure from several factors such as age and diabetes mellitus. 5-trans-Bimatoprost also has hypotensive effects and can be used for patients with high blood pressure or heart failure. 5-trans-Bimatoprost was first synthesized in 1974 and has been shown to have a structural similarity to anandamide, which is an endocannabinoid that binds to CB1 receptors in the brain. This chemical structure may explain why 5-trans-Bimatoprost has similar biological effects as anandamide
Notice:Our products are intended for lab use only. For any other use, please contact us.
Chemical properties
Molecular weight:415.57 g/mol
Formula:C25H37NO4
Purity:Min. 95 Area-%
Color/Form:Clear Liquid
InChI:InChI=1S/C25H37NO4/c1-2-26-25(30)13-9-4-3-8-12-21-22(24(29)18-23(21)28)17-16-20(27)15-14-19-10-6-5-7-11-19/h3,5-8,10-11,16-17,20-24,27-29H,2,4,9,12-15,18H2,1H3,(H,26,30)/b8-3+,17-16+/t20-,21+,22+,23-,24+/m0/s1
InChI key:InChIKey=AQOKCDNYWBIDND-ABRBVVEGSA-N
SMILES:CCNC(=O)CCC/C=C/C[C@H]1[C@@H](O)C[C@@H](O)[C@@H]1/C=C/[C@@H](O)CCc1ccccc1
Technical inquiry about: 5-trans-Bimatoprost
Please use instead the cart to request a quotation or an order
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.